Panagora Asset Management Inc Magenta Therapeutics, Inc. Transaction History

Panagora Asset Management Inc

  • $20.5 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021
SELL
$6.07 - $9.89 $3,429 - $5,587
-565 Closed
0 $0
Q2 2021

Aug 11, 2021
BUY
$9.76 - $14.15 $5,514 - $7,994
565 New
565 $6,000
Q4 2020

Feb 10, 2021
SELL
$6.1 - $7.94 $17,940 - $23,351
-2,941 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$6.52 - $8.94 $19,175 - $26,292
2,941 New
2,941 $20,000

Others Institutions Holding MGTA

# of Institutions
2
Shares Held
442K
Call Options Held
0
Put Options Held
0
View Full List

About Magenta Therapeutics, Inc.

MGTA Quotes by TradingView
  • Ticker MGTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,890,500
  • Description
  • Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...
More about MGTA
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email